Fredericus Colen
Directeur/Membre du Conseil chez ONWARD MEDICAL N.V.
Fortune : 414 691 $ au 31/05/2024
Profil
Mr. Fredericus A.
Colen is a Chairman at Xeltis AG and an Independent Non-Executive Director at Onward Medical NV.
He is on the Board of Directors at Onward Medical SA, Onward Medical NV and College of Science & Engineering.
Mr. Colen was previously employed as an Independent Director by Volato Group, Inc., a Chief Executive Officer by Acarix AB, a President & Chief Executive Officer by Neovasc, Inc., an Independent Director by Middle Peak Medical, Inc., a President & Chief Executive Officer by BeneChill, Inc., a President by Cardiac Rhythm Management, a Chief Technology Officer & Executive VP by Boston Scientific Corp., a Vice President by International Association of Medical Prosthesis Manufacturers, and a VP-Cardiovascular Research & Development by SCIMED Life Systems, Inc. (Minnesota).
He also served on the board at Mölnlycke Health Care AB.
He received his graduate degree from RWTH Aachen University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ONWARD MEDICAL N.V.
0,20% | 25/03/2024 | 69 962 ( 0,20% ) | 414 691 $ | 31/05/2024 |
Postes actifs de Fredericus Colen
| Sociétés | Poste | Début |
|---|---|---|
| ONWARD MEDICAL N.V. | Directeur/Membre du Conseil | 01/01/2017 |
Onward Medical SA
 Onward Medical SA BiotechnologyHealth Technology ONWARD Inc develops medical devices. It also provides stimulation system to rehabilitate individuals with spinal cord injury. The company was founded by Jocelyn Bloch, Sjaak Deckers, Grégoire Courtine, and Vincent Delattre in December 2014 and is headquartered in Lausanne, Switzerland. | Directeur/Membre du Conseil | 01/01/2017 |
| College of Science & Engineering | Directeur/Membre du Conseil | - |
Xeltis AG
 Xeltis AG Medical SpecialtiesHealth Technology Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland. | Président | 01/01/2023 |
Anciens postes connus de Fredericus Colen
| Sociétés | Poste | Fin |
|---|---|---|
| ACARIX AB | Directeur Général | 01/02/2024 |
| NEOVASC INC. | Directeur Général | 01/04/2023 |
Mölnlycke Health Care AB
 Mölnlycke Health Care AB Medical SpecialtiesHealth Technology Mölnlycke Health Care AB manufactures surgical and wound care products. It offers custom procedure trays, examination gloves, dental products, staff clothing, surgical drapes and absorbent dressings. The firm's brands include BARRIER, Biogel, HiBi and ProcedurePak, Mepilex, Mepitel, Mepore, Mefix, Tubifast, Tubigrip and Xelma. The company was founded by Gustaf Ferdinand Hennig in 1849 and is headquartered in Goteborg, Sweden. | Directeur/Membre du Conseil | 01/03/2017 |
Middle Peak Medical, Inc.
 Middle Peak Medical, Inc. Medical SpecialtiesHealth Technology Middle Peak Medical, Inc. develops implants for treatment of mitral valve disease. Its technology has application in both percutaneous catheter-based intervention and in minimally invasive or open-heart cardiac surgery. The company was founded by Michael D. Lesh and Alexander Khairkhahan in 2011 and is headquartered in Palo Alto, CA. | Directeur/Membre du Conseil | 01/02/2017 |
Formation de Fredericus Colen
| RWTH Aachen University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BOSTON SCIENTIFIC CORPORATION | Health Technology |
| ACARIX AB | Health Technology |
| ONWARD MEDICAL N.V. | Commercial Services |
| Entreprise privées | 9 |
|---|---|
SCIMED Life Systems, Inc. (Minnesota)
 SCIMED Life Systems, Inc. (Minnesota) Medical SpecialtiesHealth Technology Part of Boston Scientific Corp., SCIMED Life Systems, Inc. is a company that specializes in artery cleaning angioplasty catheters. The company is based in Osseo, MN. The company was founded by Lawrence L. Horsch. SCIMED Life Systems, Inc. (Minnesota) was acquired by Boston Scientific Corp. on February 27, 1995 for $865 million. | Health Technology |
BeneChill, Inc.
 BeneChill, Inc. Medical SpecialtiesHealth Technology BeneChill, Inc. develops non-invasive cooling technology for cerebral ischemia treatment. The company was founded by Michael L. Berman and Denise Barbut in 2004 is headquartered in San Diego, CA. | Health Technology |
Cardiac Rhythm Management
 Cardiac Rhythm Management Medical SpecialtiesHealth Technology Part of Japan Lifeline Co., Ltd., Cardiac Rhythm Management is a company that manufactures implantable devices to treat arrhythmias. The company is based in Sylmar, CA. | Health Technology |
| International Association of Medical Prosthesis Manufacturers | |
Neovasc, Inc.
 Neovasc, Inc. Medical SpecialtiesHealth Technology Neovasc, Inc. engages in the development, manufacture and marketing of medical devices. It focuses on Neovast Tiara and Neovasc Reducer products. The company was founded on November 2, 2000 and is headquartered in Richmond, Canada. | Health Technology |
Mölnlycke Health Care AB
Mölnlycke Health Care AB Medical SpecialtiesHealth Technology Mölnlycke Health Care AB manufactures surgical and wound care products. It offers custom procedure trays, examination gloves, dental products, staff clothing, surgical drapes and absorbent dressings. The firm's brands include BARRIER, Biogel, HiBi and ProcedurePak, Mepilex, Mepitel, Mepore, Mefix, Tubifast, Tubigrip and Xelma. The company was founded by Gustaf Ferdinand Hennig in 1849 and is headquartered in Goteborg, Sweden. | Health Technology |
Xeltis AG
Xeltis AG Medical SpecialtiesHealth Technology Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland. | Health Technology |
Middle Peak Medical, Inc.
Middle Peak Medical, Inc. Medical SpecialtiesHealth Technology Middle Peak Medical, Inc. develops implants for treatment of mitral valve disease. Its technology has application in both percutaneous catheter-based intervention and in minimally invasive or open-heart cardiac surgery. The company was founded by Michael D. Lesh and Alexander Khairkhahan in 2011 and is headquartered in Palo Alto, CA. | Health Technology |
Onward Medical SA
Onward Medical SA BiotechnologyHealth Technology ONWARD Inc develops medical devices. It also provides stimulation system to rehabilitate individuals with spinal cord injury. The company was founded by Jocelyn Bloch, Sjaak Deckers, Grégoire Courtine, and Vincent Delattre in December 2014 and is headquartered in Lausanne, Switzerland. | Health Technology |
